Baird Medical Investment (NASDAQ:BDMD) Stock Price Up 1.9% – Time to Buy?

Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s stock price rose 1.9% on Friday . The stock traded as high as $1.14 and last traded at $1.10. 43,911 shares changed hands during trading, an increase of 22% from the average daily volume of 36,029 shares. The stock had previously closed at $1.08.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Baird Medical Investment in a report on Wednesday, August 5th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Baird Medical Investment Stock Performance

The business has a 50-day moving average price of $1.12 and a 200-day moving average price of $1.54.

Institutional Trading of Baird Medical Investment

A number of hedge funds have recently bought and sold shares of the stock. Citadel Advisors LLC purchased a new position in shares of Baird Medical Investment in the 2nd quarter valued at $63,000. Jane Street Group LLC bought a new stake in Baird Medical Investment during the second quarter valued at about $142,000. Finally, Geode Capital Management LLC grew its stake in Baird Medical Investment by 59.7% in the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock valued at $93,000 after purchasing an additional 9,511 shares during the last quarter. Hedge funds and other institutional investors own 19.78% of the company’s stock.

Baird Medical Investment Company Profile

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.